Rua Life Sciences Plc logo

Rua Life Sciences Plc(LSE) RUA

Market Cap£18.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)-98%
5 Year-79%
1 Year+151%
1 Month+7%
£0.29
-3.51%
-0.01Today
Rua Life Sciences Plc last closing stock price
MetricPriceDate
Last closeGBX 28.902026-10-01
Rua Life Sciences Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.09%GBX 27.502026-09-24
1 month+7.04%GBX 27.002026-09-01
3 month+52.11%GBX 19.002026-07-03
Year to date+106.43%GBX 14.002025-12-31
1 year+151.3%GBX 11.502025-10-01
3 year+83.49%GBX 15.752023-10-02
5 year-79.36%GBX 140.002021-10-01
Since inception-97.69%GBX 12.571997-02-26

Rua Life Sciences Plc Financials at a Glance

Market Cap

£18.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£8.57M

Net Income (TTM)

-£144.33K

EPS (TTM)

£0.00

P/E Ratio

63.04

Dividend

£0.00

Beta (Volatility)

-0.13 (Low)

Price

£0.29

Volume

139,771

Open

£0.29

Previous Close

£0.29

Daily Range

£0.28 - £0.29

52-Week Range

£0.11 - £0.31

Estimated Earnings Date

Jan 25, 2027

RUA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rua Life Sciences Plc

RUA Life Sciences plc specializes in delivering advanced polymers and services to the global medical device sector. The company focuses on developing and manufacturing innovative medical devices, including proprietary implantable co-polymers for cardiac and urological applications.

Products and Services
  • Specialized polymers for medical devices
  • Contract manufacturing services for medical device development
  • Licensing of proprietary technologies, including Elast-Eon and ECSil
Growth Outlook
  • Expansion into new international markets is underway
  • Development of innovative polymer-sealed grafts and heart valves is ongoing
  • Increased demand for advanced medical devices supports growth potential
Financial Highlights
  • Recent quarterly revenue of £2.59 million shows strong market presence
  • Trailing twelve months gross profit margin stands at 68.56%
  • Current ratio of 4.64 indicates strong liquidity position
RUA Life Sciences plc operates in the healthcare sector, focusing on the medical devices industry. The company has established a reputation for innovation, particularly in the development of specialized polymers that enhance the performance of medical devices. With a commitment to research and development, RUA is positioned to capitalize on the growing demand for advanced medical solutions. The recent financial performance indicates a solid foundation, with a notable gross profit margin and a strong liquidity position, suggesting the company is well-equipped to navigate future challenges and opportunities in the medical device market.
AI Generated • Sep 29, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Bill Brown

Website

www.aortech.com

Headquarters

Irvine, SC KA11 5AN, GB

RUA Financials

Key Financial Metrics (TTM)

Gross Margin

68.56%

Operating Margin

-18.54%

Net Income Margin

-3.26%

Return on Equity

-2.03%

Return on Capital

-10.41%

Return on Assets

-1.59%

Earnings Yield

1.59%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£18.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

62.06M

Volume

139.77K

Avg. Volume

160.24K

Financials (TTM)

Gross Profit

£6.05M

Operating Income

-£1.82M

EBITDA

£17.67K

Operating Cash Flow

-£352.00K

Capital Expenditure

-£223.00K

Free Cash Flow

-£575.00K

Cash & ST Invst.

£3.25M

Total Debt

£1.35M

Rua Life Sciences Plc Performance Analysis

Rua Life Sciences Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31GBP 2,179,00034.1%
20242024-03-31GBP 2,191,0000.6%
20252025-03-31GBP 4,113,00087.7%
20252025-09-30GBP 4,459,35687.7%
Rua Life Sciences Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-309.1%
Q42025-03-3169.9%
Q22025-09-30-27.8%
Q42025-09-3038.4%
Rua Life Sciences Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31GBP -0.09-3.1%
20242024-03-31GBP -0.04-52.5%
20252025-03-31GBP 0.00N/A
20252025-09-30GBP -0.00N/A
Rua Life Sciences Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30247.7%
Q42025-03-31-154.0%
Q22025-09-30176.5%
Q42025-09-30-229.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£2.59M

+85.3%

Gross Profit

£1.66M

+50.9%

Gross Margin

64.12%

N/A

Market Cap

£18.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£305.04K

N/A

Employees

59

N/A

Net Income

-£630.00K

-46.5%

EBITDA

-£1.10M

-175.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£3.25M

-17.3%

Total Debt

£1.35M

+248.1%

Accounts Receivable

£1.25M

+135.0%

Inventory

£894.00K

+698.2%

Long Term Debt

£1.12M

+311.8%

Short Term Debt

£234.00K

+100.0%

Return on Assets

-1.59%

N/A

Return on Invested Capital

-10.39%

N/A

Free Cash Flow

-£300.00K

+34.5%

Operating Cash Flow

-£166.00K

+62.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GDR.LGenedrive Plc
£0.01+0.08%
SUN.LSurgical Innovations Group plc
£0.00+0.00%
CNSL.LCambridge Nutritional Sciences plc
£0.02+0.00%
AGL.LCelLBxHealth plc
£0.01-5.64%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$13.29+4.98%
HYGiShares Trust - iShares iBoxx $ High Yieldorate Bond ETF
$76.90+0.04%
NKENike
$35.15-0.71%
INTCIntel
$120.00-0.19%

Questions About RUA

What is the current price of Rua Life Sciences Plc?

Rua Life Sciences Plc is trading at £0.29 per share.

What is the 52-week range for Rua Life Sciences Plc?

Over the past 52 weeks, Rua Life Sciences Plc has traded between £0.11 and £0.31.

How much debt does Rua Life Sciences Plc have?

As of the most recent reporting period, Rua Life Sciences Plc reported total debt of £794.00K.

How much cash does Rua Life Sciences Plc have on hand?

Rua Life Sciences Plc reported £3.25M in cash and cash equivalents in its most recent financial results.

What is Rua Life Sciences Plc’s dividend yield?

Rua Life Sciences Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services